COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 695: Articles 6941-6950  | Next

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by Booster Vaccination or BA.2 Breakthrough Infection Sera
Wang, X., Ai, J., Li, X., Zhao, X., Wu, J., Zhang, H., He, X., Zhao, C., Qiao, R., Li, M., Cui, Y., Chen, Y., Yang, L., Hu, Z., Xu, C., Zhang, W., Wang, P.
10.1101/2022.08.04.502716 — Posted: 2022-08-06
Early Side Effects after Administration of the 1st Dose of Oxford-AstraZeneca Vaccine
Singh, P., Faisal, A. R., Shah, M. H., Saeed, A., Younas, H., Butt, U. S., Pudasaini, S., Pasha, A. R., Rehman, U.
10.1101/2022.08.04.22278415 — Posted: 2022-08-06
Forecasting COVID-19 activity in Australia to support pandemic response: May to October 2020
Moss, R., Price, D. J., Golding, N., Dawson, P., McVernon, J., Hyndman, R. J., Shearer, F. M., McCaw, J. M.
10.1101/2022.08.04.22278391 — Posted: 2022-08-06
Intra-pulmonary and intra-cardiac shunts in adult COVID-19 versus non-COVID ARDS ICU patients using echocardiography and contrast bubble studies (COVID-Shunt Study): a prospective, observational cohort study
Lau, V. I., Mah, G., Wang, X. M., Byker, L., Robinson, A., Milovanovic, L., Alherbish, A., Odenbach, J., Vadeanu, C., Lu, D., Smyth, L., Rohatensky, M., Whiteside, B., Gregoire, P., Luksun, W., Van Diepen, S., Anderson, D., Verma, S., Slemko, J., Brindley, P., Kutsogiannis, D. J., Jacka, M., Shaw, A., Wheatley, M., Windram, J., Opgenorth, D., Baig, N., Rewa, O. G., Bagshaw, S. M., Buchanan, B. M.
10.1101/2022.08.04.22278445 — Posted: 2022-08-06
Direct and indirect effects of the COVID-19 pandemic on mortality in Switzerland: A population-based study
Riou, J., Hauser, A., Fesser, A., Althaus, C. L., Egger, M., Konstantinoudis, G.
10.1101/2022.08.05.22278458 — Posted: 2022-08-06
Differential Impacts of Perceived Social Support on Alcohol and Cannabis Use in Young Adults: Lessons from the COVID-19 Pandemic
Lo, L. A., Blumberg, M. J., Harrison, G. W., Dodwell, A., Irwin, S. H., Olmstead, M. C.
10.1101/2022.08.04.22278446 — Posted: 2022-08-06
Performance of Screening for SARS-CoV-2 using Rapid Antigen Tests to Detect Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infection: findings from the Test Us at Home prospective cohort study
Soni, A., Herbert, C., Lin, H., Pretz, C., Stamegna, P., Orwig, T., Wright, C., Tarrant, S., Behar, S., Suvarna, T., Schrader, S., Harman, E., Nowak, C., Kheterpal, V., Rao, L. V., Cashman, L., Orvek, E., Ayturk, D., Lazar, P., Wang, Z., Barton, B., Achenbach, C., Murphy, R., Manabe, Y., Robinson, M., Wang, B., Pandey, S., Colubri, A., O'Connor, L., Lemon, S., Fahey, N., Luzuriaga, K. L., Hafer, N., Heetderks, B., Broach, J., McManus, D. D.
10.1101/2022.08.05.22278466 — Posted: 2022-08-06
Determining population-level allocation strategies for COVID-19 treatments in the United States using a quantitative framework, a case study using nirmatrelvir/ritonavir
Savinkina, A., Gonsalves, G. S., Ross, J. S., Paltiel, A. D.
10.1101/2022.08.04.22278431 — Posted: 2022-08-06
A Reagent and Virus Benchmarking Panel for a Uniform Analytical Performance Assessment of N Antigen-Based Diagnostic Tests for COVID-19
Golden, A. L., Cantera, J., Lillis, L., Phan, T. T., Slater, H., Webb, E. J., Peck, R. B., Domingo, G. J., Boyle, D. S.
10.1101/2022.08.03.22278351 — Posted: 2022-08-06
Optimization of Ventilation Therapy Prioritization Strategies among Patients with COVID-19: Lessons Learned from Real-World Data of nearly 600,000 Hospitalized Patients
Abbasi-Kangevari, M., Ghanbari, A., Malekpour, M.-R., Ghamari, S.-H., Azadnajafabad, S., Saeedi Moghaddam, S., Keykhaei, M., Haghshenas, R., Golestani, A., Rashidi, M.-M., Ghasemi, E., Rezaei, N., Jamshidi, H. R., Rezaei, N., Larijani, B.
10.1101/2022.08.04.22278438 — Posted: 2022-08-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).